A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
Public ClinicalTrials.gov record NCT03933215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effectiveness, patient-reported outcomes (PROs) and safety of cladribine tablets in participants with relapsing forms of multiple sclerosis (RMS) including relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple sclerosis (aSPMS),who transition to cladribine tablets after suboptimal response to any injectable disease-modifying drugs (DMDs) approved in the United States (US) for RMS in a real-world setting.
Study identification
- NCT ID
- NCT03933215
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2019 (Actual)
- Primary completion
- Mar 30, 2024 (Actual)
- Completion
- Mar 30, 2024 (Actual)
- Last update posted
- Apr 29, 2025
2019 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| HCA Research Institute | Englewood | Colorado | 80113 | — |
| Advanced Neurosciences Research | Fort Collins | Colorado | 80528 | — |
| Prairie Education & Research | Springfield | Illinois | 62702 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| College Park Family Care Center | Overland Park | Kansas | 66212 | — |
| The Elliot Lewis Center for Multiple Sclerosis Care, LLC | Wellesley | Massachusetts | 02481 | — |
| UMASS - Neurology | Worcester | Massachusetts | 01655 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Memorial Healthcare | Owosso | Michigan | 48867 | — |
| Minneapolis Clinic of Neurology - Neurology | Minneapolis | Minnesota | 55422 | — |
| Guilford Neurologic Associates | Greensboro | North Carolina | 27405 | — |
| Neurology Center of San Antonio | San Antonio | Texas | 78258 | — |
| Blacksburg Neurology, PC | Christiansburg | Virginia | 24073 | — |
| Neurological Associates | Richmond | Virginia | 23229 | — |
| VCU Medical Center - Pediatric Neurology | Richmond | Virginia | 23298-0211 | — |
| Sentara Ambulatory Care Center | Virginia Beach | Virginia | 23456 | — |
| MS Center of Evergreen | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03933215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03933215 live on ClinicalTrials.gov.